News
Hosted on MSN
DCC plc Advances £100 Million Share Buyback Program
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from DCC ...
THIS IS KCRA THREE NEWS AT 430. WELL, IT WAS $100 MILLION GRANT PROGRAM MEANT TO HELP CANNABIS BUSINESSES IN CALIFORNIA. SO, IS IT WORKING? THAT’S THE QUESTION A STATE AUDITOR RELEASED TODAY IS ...
DANVILLE, Va. (WDBJ) - Plans are lifting off to expand the Danville Regional Airport’s aviation training program. Right now, Averett University’s Aeronautics Program takes place at the airport. Soon, ...
Registered non-profits and charities can now apply for a grant to get free yearly access (valued at $1800) to the powerful Legalese Decoder Business plan. We understand that legal complexities can be ...
The State University of New York is expanding a free program aimed at growing the state’s workforce of direct support professionals. Direct support professionals, or DSPs, are trained to care for and ...
What are DCC sound decoders? Well, to put it briefly: A sound decoder is a computer on a chip that receives and interprets signals sent from the DCC base station and puts out an analog signal that ...
DANVILLE, Va. (WDBJ) - Danville Community College is now offering a CDL Training program. DCC is partnering with Ancora Education to provide a full-time and part-time truck driving course. 8 students ...
DANVILLE, Va. (WSET) — The Danville Community College is introducing a new training program to address both regional needs and a nationwide shortage of CDL-licensed truck drivers. DCC in partnership ...
SUMTER, S.C. — Tuesday was the first day of the Emerging Leaders program. This nine-month series of workshops teaches students in Sumter and Lee Counties how to get involved with their community.
Deciphera Pharmaceuticals Presents Preclinical Data from DCC-3116 Program at the AACR Annual Meeting
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results